ReMedys Founder and CMC Regulatory Affairs
Dr. Toronto received her PhD from University of California at Davis and has 14 years of international pharmaceutical development experience gained from leadership and technical positions at both contract-manufacturing organizations and in pharmaceutical industry.
Dr. Toronto is the principle of CMCplus, an independent consulting firm, and specializes in developing CMC regulatory strategies from preclinical to phase III clinical trials. She has implemented successful manufacturing and regulatory strategies for over 40 clinical candidates following both EMEA and FDA regulations. She is an expert in the field of analytical method development and validation in accordance with ICH guidelines and maintains a strong background in compliance, quality systems and cGMP production. Dr. Toronto shall focus primarily on developing and sourcing drug supply and ensuring regulatory compliance of materials used in clinical trial studies.